215 related articles for article (PubMed ID: 19754366)
1. Blood-brain interfaces and bilirubin-induced neurological diseases.
Ghersi-Egea JF; Gazzin S; Strazielle N
Curr Pharm Des; 2009; 15(25):2893-907. PubMed ID: 19754366
[TBL] [Abstract][Full Text] [Related]
2. Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agents.
Fernandes A; Brites D
Curr Pharm Des; 2009; 15(25):2915-26. PubMed ID: 19754368
[TBL] [Abstract][Full Text] [Related]
3. Bilirubin induced neurological damage: from the cell to the newborn.
Ostrow JD; Tiribelli C
Curr Pharm Des; 2009; 15(25):2868. PubMed ID: 19754363
[No Abstract] [Full Text] [Related]
4. The role of ABC transporters in protecting cells from bilirubin toxicity.
Bellarosa C; Bortolussi G; Tiribelli C
Curr Pharm Des; 2009; 15(25):2884-92. PubMed ID: 19754365
[TBL] [Abstract][Full Text] [Related]
5. Vascular network expansion, integrity of blood-brain interfaces, and cerebrospinal fluid cytokine concentration during postnatal development in the normal and jaundiced rat.
Blondel S; Strazielle N; Amara A; Guy R; Bain C; Rose A; Guibaud L; Tiribelli C; Gazzin S; Ghersi-Egea JF
Fluids Barriers CNS; 2022 Jun; 19(1):47. PubMed ID: 35672829
[TBL] [Abstract][Full Text] [Related]
6. Bilirubin chemistry and metabolism; harmful and protective aspects.
Vítek L; Ostrow JD
Curr Pharm Des; 2009; 15(25):2869-83. PubMed ID: 19754364
[TBL] [Abstract][Full Text] [Related]
7. Redox state, oxidative stress, and molecular mechanisms of protective and toxic effects of bilirubin on cells.
Tell G; Gustincich S
Curr Pharm Des; 2009; 15(25):2908-14. PubMed ID: 19754367
[TBL] [Abstract][Full Text] [Related]
8. Unbound bilirubin and risk assessment in the jaundiced newborn: possibilities and limitations.
Hankø E
Pediatrics; 2006 Feb; 117(2):526-7. PubMed ID: 16452374
[No Abstract] [Full Text] [Related]
9. Bilirubin binding and kernicterus.
Diamond I
Adv Pediatr; 1969; 16():99-119. PubMed ID: 4899063
[No Abstract] [Full Text] [Related]
10. Glutathione Conjugation at the Blood-CSF Barrier Efficiently Prevents Exposure of the Developing Brain Fluid Environment to Blood-Borne Reactive Electrophilic Substances.
Kratzer I; Strazielle N; Saudrais E; Mönkkönen K; Malleval C; Blondel S; Ghersi-Egea JF
J Neurosci; 2018 Apr; 38(14):3466-3479. PubMed ID: 29507144
[TBL] [Abstract][Full Text] [Related]
11. Why the Premature Brain Is More Prone to Bilirubin-induced Injury.
Jain L
Clin Perinatol; 2016 Jun; 43(2):xv-xvi. PubMed ID: 27235215
[No Abstract] [Full Text] [Related]
12. Pharmacological therapies for unconjugated hyperbilirubinemia.
Cuperus FJ; Hafkamp AM; Hulzebos CV; Verkade HJ
Curr Pharm Des; 2009; 15(25):2927-38. PubMed ID: 19754369
[TBL] [Abstract][Full Text] [Related]
13. Bilirubin-Induced Neurotoxicity in the Preterm Neonate.
Watchko JF
Clin Perinatol; 2016 Jun; 43(2):297-311. PubMed ID: 27235209
[TBL] [Abstract][Full Text] [Related]
14. Bilirubin Binding Capacity in the Preterm Neonate.
Amin SB
Clin Perinatol; 2016 Jun; 43(2):241-57. PubMed ID: 27235205
[TBL] [Abstract][Full Text] [Related]
15. Transport and metabolism at blood-brain interfaces and in neural cells: relevance to bilirubin-induced encephalopathy.
Gazzin S; Strazielle N; Tiribelli C; Ghersi-Egea JF
Front Pharmacol; 2012; 3():89. PubMed ID: 22629246
[TBL] [Abstract][Full Text] [Related]
16. Hyperbilirubinemia, hemolysis, and increased bilirubin neurotoxicity.
Kaplan M; Bromiker R; Hammerman C
Semin Perinatol; 2014 Nov; 38(7):429-37. PubMed ID: 25284470
[TBL] [Abstract][Full Text] [Related]
17. Blood-brain interfaces and cerebral drug bioavailability.
Ghersi-Egea JF; Mönkkönen KS; Schmitt C; Honnorat J; Fèvre-Montange M; Strazielle N
Rev Neurol (Paris); 2009 Dec; 165(12):1029-38. PubMed ID: 19913860
[TBL] [Abstract][Full Text] [Related]
18. Modulation of bilirubin neurotoxicity by the Abcb1 transporter in the Ugt1-/- lethal mouse model of neonatal hyperbilirubinemia.
Bockor L; Bortolussi G; Vodret S; Iaconcig A; Jašprová J; Zelenka J; Vitek L; Tiribelli C; Muro AF
Hum Mol Genet; 2017 Jan; 26(1):145-157. PubMed ID: 28025333
[TBL] [Abstract][Full Text] [Related]
19. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns.
Wennberg RP; Ahlfors CE; Bhutani VK; Johnson LH; Shapiro SM
Pediatrics; 2006 Feb; 117(2):474-85. PubMed ID: 16452368
[TBL] [Abstract][Full Text] [Related]
20. Movement disorders due to bilirubin toxicity.
Rose J; Vassar R
Semin Fetal Neonatal Med; 2015 Feb; 20(1):20-25. PubMed ID: 25524299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
